The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index, and 1 are not checked yet.
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis
Open accessAbstract
The diagnosis of amyotrophic lateral sclerosis can be challenging due to its heterogeneity in clinical presentation and overlap with other neurological disorders. Diagnosis early in the disease course can improve outcomes as timely interventions can slow disease progression. An evolving awareness of disease genotypes and phenotypes and new diagnostic criteria, such as the recent Gold Coast criteria, could expedite diagnosis. Improved prognosis, such as that achieved with the survival model from the European Network for the Cure of ALS, could inform the patient and their family about disease course and improve end-of-life planning. Novel staging and scoring systems can help monitor disease progression and might potentially serve as clinical trial outcomes. Lastly, new tools, such as fluid biomarkers, imaging modalities, and neuromuscular electrophysiological measurements, might increase diagnostic and prognostic accuracy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“monogenic ALS mutations may still exhibit incomplete penetrance or delayed onset [8]”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“as exposure to certain environmental factors might modify the risk the mutations confer [8].”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citationCedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., Mclaughlin, P., Snowden, J., Mioshi, E., Roberts-South, A., Benatar, M., HortobáGyi, T., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1267768 · Cited by 909
Chiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862
Self-citationThe phenotypic variability of amyotrophic lateral sclerosis
Swinnen, B., & Robberecht, W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.184 · Cited by 647
Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study
Chiò, A., Calvo, A., Moglia, C., Mazzini, L., Mora, G., & PARALS study group (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.235952 · Cited by 626
Self-citationA proposal for new diagnostic criteria for ALS
Shefner, J. M., Al‐Chalabi, A., Baker, M. R., Cui, L., de Carvalho, M. A., Eisen, A., Großkreutz, J., Hardiman, O. M., Henderson, R. D., Matamala, J. M., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.04.005 · Cited by 622
Self-citationNovel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Chia, R., Chiò, A., & Traynor, B. J. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30401-5 · Cited by 592
Self-citation
Research works printed but not linked: 1
- Pinto-Grau, 2020, Patterns of language impairment in early ALS, Neurol Clin Pract, 11, e634
Cited by
Sorted by citations
Items 401–493 of 493
Additional file 7 of Oligogenic basis of premature ovarian insufficiency: an observational study
Long, P., Wang, L., Tan, H., Quan, R., Hu, Z., Zeng, M., Deng, Z., Huang, H., Greenbaum, J., HongWen, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26676557
Aousji, O., Feldengut, S., Antonucci, S., Schön, M., Boeckers, T. M., Matschke, J., Mawrin, C., Ludolph, A. C., Tredici, K. D., Roselli, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26606371
Aousji, O., Feldengut, S., Antonucci, S., Schön, M., Boeckers, T. M., Matschke, J., Mawrin, C., Ludolph, A. C., Tredici, K. D., Roselli, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26606365
Aousji, O., Feldengut, S., Antonucci, S., Schön, M., Boeckers, T. M., Matschke, J., Mawrin, C., Ludolph, A. C., Tredici, K. D., Roselli, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26606362
Additional file 3 of Oligogenic basis of premature ovarian insufficiency: an observational study
Long, P., Wang, L., Tan, H., Quan, R., Hu, Z., Zeng, M., Deng, Z., Huang, H., Greenbaum, J., HongWen, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26676545
Additional file 2 of Oligogenic basis of premature ovarian insufficiency: an observational study
Long, P., Wang, L., Tan, H., Quan, R., Hu, Z., Zeng, M., Deng, Z., Huang, H., Greenbaum, J., HongWen, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26676542
Dai, T., Lou, J., Kong, D., Li, J., Ren, Q., Chen, Y., Sun, S., Yun, Y., Sun, X., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25633069
Additional file 6 of Oligogenic basis of premature ovarian insufficiency: an observational study
Long, P., Wang, L., Tan, H., Quan, R., Hu, Z., Zeng, M., Deng, Z., Huang, H., Greenbaum, J., HongWen, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26676554
Aousji, O., Feldengut, S., Antonucci, S., Schön, M., Boeckers, T. M., Matschke, J., Mawrin, C., Ludolph, A. C., Tredici, K. D., Roselli, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26606368
Dai, T., Lou, J., Kong, D., Li, J., Ren, Q., Chen, Y., Sun, S., Yun, Y., Sun, X., Yang, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25632979
Additional file 1 of Oligogenic basis of premature ovarian insufficiency: an observational study
Long, P., Wang, L., Tan, H., Quan, R., Hu, Z., Zeng, M., Deng, Z., Huang, H., Greenbaum, J., HongWen, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26676539
Additional file 8 of Oligogenic basis of premature ovarian insufficiency: an observational study
Long, P., Wang, L., Tan, H., Quan, R., Hu, Z., Zeng, M., Deng, Z., Huang, H., Greenbaum, J., HongWen, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26676560
Additional file 4 of Oligogenic basis of premature ovarian insufficiency: an observational study
Long, P., Wang, L., Tan, H., Quan, R., Hu, Z., Zeng, M., Deng, Z., Huang, H., Greenbaum, J., HongWen, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26676548
Cai, R., Yang, J., Wu, L., Liu, Y., Wang, X., Zheng, Q., & Li, L. (2024) · Figshare · doi:10.6084/m9.figshare.26676284
Additional file 5 of Oligogenic basis of premature ovarian insufficiency: an observational study
Long, P., Wang, L., Tan, H., Quan, R., Hu, Z., Zeng, M., Deng, Z., Huang, H., Greenbaum, J., HongWen, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26676551
Meditation intervention in a person with amyotrophic lateral sclerosis
Gomes, V. D. M., & Ogassawara, T. B. C. (2025) · Fisioterapia em Movimento · doi:10.1590/fm.2025.38303
Hu, N., Tian, H., Ding, J., Shen, D., Yang, X., Niu, J., liu, M., & Cui, L. (2026) · Neurology and Clinical Neuroscience · doi:10.1002/ncn3.70075
Li, C., Wang, Y., Liang, S., Shi, H., Mao, X., Wang, X., & Mo, D. (2026) · ImmunoTargets and Therapy · doi:10.2147/itt.s564201
Yang, X., Huang, S., Wang, Y., Yuan, J., & Yao, X. (2026) · ImmunoTargets and Therapy · doi:10.2147/itt.s566733
Emerging Trends in Neurodegenerative Disease Treatment
Pazhamalai, V., Gokul, V., Madhumitha, L., Kumar, P. M., Meenambiga, S. S., Romauld, S. I., & M., H. N. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-1365-8.ch003
Yi, W., Xu, Z., Feng, D., Guan, L., Tang, J., & Zou, Y. F. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02616
Age-period-cohort effect on motor neuron disease mortality in the United States, 2001–2020
Raymond, J. S., Larson, T. C., III, Nair, T., Kaufman, J., Horton, D. K., Weisskopf, M. G., Mohidul, S., & Mehta, P. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1751690
Advanced management options for patients with amyotrophic lateral sclerosis
Mandra, E. V., & Parfenov, V. A. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-514
Lipid Metabolic Mediators Bridge Ischemic Heart Disease and Amyotrophic Lateral Sclerosis
Ma, H., Liu, M., Yang, J., Li, J., He, A., Li, M., Guan, W., Shi, J., & Teng, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05693-3
Liu, J., Zhou, L., Deng, Y., & Xu, R. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00221 · Cited by 1
Natural Killer Cell Dysregulation During ALS Disease Progression
Goutman, S. A., Guo, K., Park, J., Jang, D., Teener, S. J., Webber‐Davis, I. F., Famie, J. P., Piecuch, C. E., Hur, J., & Murdock, B. J. (2026) · Neurology Open Access · doi:10.1212/wn9.0000000000000067
Self-citationHanyu, R., Yokoseki, A., Onodera, O., & Koike, Y. M. (2026) · BMC Neurology · doi:10.1186/s12883-026-04755-2
Advances and Challenges in the Use of Spinal Cord Organoids in ALS
Zhang, Y., Chen, B., Lin, Y., Kang, D., & Zhao, T. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin44709
Zarco-Martín, M. T., Andreo-López, M. C., Yagui-Beltrán, M. S., & Soto, M. L. F. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1713253
Computational Screening of Natural Products Against SOD1 to Identify Potential ALS TherapeuticsPreprint
Iqbal, N., Kandeel, M. K., Beigh, S., Rasheed, F., Iqbal, M. N., & Ullah, S. (2026) · Research Square · doi:10.21203/rs.3.rs-8879349/v1
Huang, N., Cai, Z.-W., Zhuang, S.-P., Lin, H.-Y., Chen, S., Zou, Z., Wu, Y., & Chen, H.-J. (2026) · BMC Medicine · doi:10.1186/s12916-026-04770-7
Brain Folding Trajectories in Amyotrophic Lateral Sclerosis
Shafie, M., Tamba, C., Bhinder, H., Kalra, S., & Pizzagalli, F. (2026) · Human Brain Mapping · doi:10.1002/hbm.70449
Axonal transport impairment as an upstream mechanism in amyotrophic lateral sclerosis pathogenesis
Gabbay, U. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1802313
Systemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum
Isik, F. I., Pickford, R., Timmins, H. C., Piguet, O., Halliday, G. M., Kiernan, M. C., & Kim, W. S. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70232
Self-citationUversky, V. N. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2648612
Etude des effets thérapeutiques de la protéine X du virus Borna chez la souris SOD1G93A
Tournezy, J. (2024) · theses.fr (ABES) · doi:10.70675/6679c9cez7694z4a71z84a3za0e24b70e3eb
Nassar, J. E., Knebel, A., Ammar, L., Singh, M., Kuris, E. O., Diebo, B. G., & Daniels, A. H. (2026) · The American Journal of Medicine · doi:10.1016/j.amjmed.2026.04.017
Physiological and pathological functions of TAF15 in neurodegenerative diseases and cancers
Liu, C., Meng, L., & Zhang, Z. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.04.066
Zhu, Y., Zhang, H., Zhang, Z., Song, G., Fu, J., & Wang, H. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.04.024
Classical HLA class II associations with ALS in Kuwait reveal a DR7–DQ2.2 risk haplotype
DASHTI, M. H., AlAbdulghafour, F., Almutairi, O., Mohammad, A., Malik, M. Z., Alrefaie, K., Nizam, R., JACOB, S., Al‐Chalabi, A., Khleifat, A. A., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1820694
Self-citationMuscle and Motor System Disability
Malviya, R., & Rajput, S. (2026) · SpringerBriefs in modern perspectives on disability research. · doi:10.1007/978-981-95-9223-4_4
Clinical and electrophysiological features for differentiating MMN from hand-onset ALS
Fang, S., Jih, K., Chao, Y.-C., Sytwu, H.-P., Shih, Y., Liao, Y. H., & Lee, Y. (2026) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001387
Kawazoe, T., Sugaya, K., Hayashi, K., Hino, K., Nakata, Y., Bokuda, K., Shimizu, T., & Takahashi, K. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70432
Bradford, E. H., DeMarco, E. C., Zocher, S., Weaver, K., Forsman, K., Hayat, G., Subramaniam, D. S., & Doherty, M. (2026) · Neurorehabilitation and neural repair · doi:10.1177/15459683261445435
Keihani, A., Hassani, M., Sajadi, S. S., Modarresi, S. A., Khoshkholgh, M., Haresabadi, M., Amani, K., Jourahmad, Z., & Ferrarelli, F. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1798525
Nanocarriers unveiling ferroptosis as a potential therapeutic target
Sithole, M. N., & Choonara, Y. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00017-9
Wheeler, A., Mehta, K., Sanders, D. L., Chin, C., Zivalic, H., Carey, J., McCaffrey, A., Pant, P., Lewenhaupt, C., Luppino, S. D., et al. (2026) · Muscle & Nerve · doi:10.1002/mus.70310
F-waves in primary lateral sclerosis: a window into spinal motoneuron hyperexcitability
Vucic, S. (2026) · Clinical Neurophysiology · doi:10.1016/j.clinph.2026.2112317
YuJing, Y., Ling, C., Wang, Z., Yuan, Y., Zhang, W., & Zhao, Y. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09175-1
Mohamed, L. A. A. H., Shalaby, M. F., Williamson, R., McLean, S. L., & Kantamneni, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.01.735805
GDF5 as a Multimodal Protector of the Motor Unit in Amyotrophic Lateral SclerosisPreprint
Bourguiba, A., Pezet, S., Traoré, M., Gentil, C., Marais, T., Fail, A., Gelin, M., Messéant, J., Meunier, P., Benkhelifa‐Ziyyat, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.30.735251
Unusual presentation of amyotrophic lateral sclerosis years after a motor-vehicle collision
Pucciarelli, D. M., Patel, R., Sawicki, S., Jain, S., & Saulino, P. A. (2026) · BMJ Case Reports · doi:10.1136/bcr-2026-272139
Yu, W., Zhao, B., Ma, M., Gao, N., Yun, Y., Sun, X., Shao, K., Lin, P., Li, W., Zhao, Y., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106884
Macpherson, C. E., Muccini, J., Blacutt, M. E., Bjalme-Evans, M., Lough, M. E., & Quinn, L. (2026) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2026.2700400
A modified frailty index to identify high-risk groups for amyotrophic lateral sclerosis
Gao, X., Chen, S., Mahabub, S., Cao, B., Deng, J., Ye, W., Fang, F., & Zou, Z. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1879866
Palliative Care Involvement in Hospitalized Amyotrophic Lateral Sclerosis Patients
Bhardwaj, S., Chakraborty, A., Mead, J., & Stilos, K. K. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23081081
White matter abnormalities in amyotrophic lateral sclerosis: a free water imaging study
Liu, Z., Yang, H., Cui, J., Guan, Z., Gao, D., 冯平勇, He, Y., Li, W., Zhao, Y., Yang, Q., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1899073
Combination of Amyotrophic Lateral Sclerosis with Alzheimer’s Disease
Владимировна, П. Е., Kutlubaev, M. A., Kuznetsova, D. R., Karimova, G., Валерьевна, К. О., & Mkhitaryan, E. A. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-02038-4
da Silva, S. T., de Souza, A. A., de Melo, L. P., Cacho, R. D. O., de Holanda, L. J., Ortiz, L. D. N., Júnior, M. E. T. D., Farias, I. B., Gonçalves, F., Nagem, D. A. P., et al. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2713034
Niu, T., Wang, F., Li, R., Liu, Q., Ma, Z., Zhou, X., Liu, T., Lin, J., Zhu, J., Yin, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-65659-2
Falls in people with amyotrophic lateral sclerosis: A prospective study
Alencar, M. A., Gonçalves, J. M. W., Sousa, D. A. K. A. D. C., Rangel, M. F. D. A., Gomes, P. C. F., & de Souza, L. C. (2026) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2026.101623
Lv, C., Zhu, W., Wen, X., & Da, Y. (2026) · ASN NEURO · doi:10.1080/17590914.2026.2715625
Gold Coast criteria for ALS diagnosis: individual participant data meta-analysis
Shrestha, N., Munn, Z., Calma, A. D., Pavey, N., Tsuji, Y., Menon, P., Padovani, A., Risi, B., Ferullo, L., Filosto, M., et al. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14046-y
Self-citationDisruption of Zinc homeostasis and its role in neurodegenerative diseases
Pereira, M. V. S., Júnior, C. A. L., & de Jesus, J. R. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.010
Wolf, J., Safer, A., Stefenelli, U., Wöhrle, J. C., Maschke, M., Nix, W. A., & Grau, A. (2026) · BMC Neurology · doi:10.1186/s12883-026-05325-2
Chowdhury, S., Kar, K., Chakraborty, P., Kuilya, M., Prajapati, B. G., Ankul Singh, S., & Sridevi, S. (2026) · Current Proteomics · doi:10.1016/j.curpro.2026.100151
Viljoen, S. J., Chaves, J. C. S., Peall, I. W., White, A. R., & Oikari, L. E. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.126168
HIMALAYA: learning from another negative phase 2 trial in ALS
Hardiman, O. M. (2026) · The Lancet Neurology · doi:10.1016/s1474-4422(26)00318-2
Self-citationMicrobiome and Diseases: Gut–Brain Axis and Neurological Disorders
de Castilhos, J., & Stein‐Thoeringer, C. K. (2026) · Springer eBooks · doi:10.1007/978-3-032-26410-7_18
Zhang, E., Oh, P., Shamas, T. L., Patwa, H. S., & Johung, K. L. (2026) · Advances in Radiation Oncology · doi:10.1016/j.adro.2026.102135
Zhang, Y., Wei, K., Lin, H., Guo, Z., Lu, Y., & Ma, T. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01987-6
Aksoylu, I. S., Azizi, L., Öijerstedt, L., Lilja, S., Álvez, M. B., Yazdani, S., Skoglund, L., Foucher, J., Juto, A., Seitz, C., et al. (2026) · medRxiv · doi:10.64898/2026.09.16.26362998
Zhao, T., Hoffman, M., Wu, G., & Belzil, V. (2026) · medRxiv · doi:10.64898/2026.09.17.26363319
Wang, Z., Xia, Y., & Zhang, G. (2026) · Bioengineering · doi:10.3390/bioengineering13091092
Expression and role of HSPA5 in environmental toxin-induced neurological disorders
Wang, Y., Lv, Y., Zhao, R., Guo, X., Gao, J., Wang, T., Yao, D., Li, X., Liu, B., & Yuan, J. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1964213
Potential Roles of Neuroimaging in Motor Neuron Disease
Kassubek, J., & Müller, H. (2026) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-026-01524-z
A neural architecture for imagined and overt speech motor dynamics
Zhao, Z., Wang, Z., Liu, Y., Qian, Y., Yin, Y., Gao, X., Yuan, B., Tong, S. X., Tian, X., Chen, G., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02456-0 · Cited by 2
Comorbidity in amyotrophic lateral sclerosis: structure and prognostic aspects
Владимировна, П. Е., & Kutlubaev, M. A. (2026) · Annals of Clinical and Experimental Neurology · doi:10.17816/acen.1483
Handling missed dose of riluzole by population pharmacokinetic model informed remedial regimen
Liu, C., Tang, Q., Yu, L., & Yu, Z. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1890355
Lv, C., Zhu, W., Wen, X., Wang, Y., Xie, N., Liu, H., Jiang, Y., Zou, W., Liu, Q., Gou, J., et al. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14178-1
Shen, C., Wu, X., Yin, H., Zuo, J.-L., Zhang, C., Cao, F., Zhang, Y., Tian, Z., Robinson, N., & Liu, J.-P. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1706211
Analysis of articulatory measures in amyotrophic lateral sclerosis
dos Santos, V. B., de Oliveira, G. S., Bressanelli, A. L., Teixeira, A. R., Padovani, M., Almeida, A. A., Rothe‐Neves, R., & Olchik, M. R. (2026) · Revista CEFAC · doi:10.1590/1982-0216/202628410625
Análise das medidas articulatórias na esclerose lateral amiotrófica
dos Santos, V. B., de Oliveira, G. S., Bressanelli, A. L., Teixeira, A. R., Padovani, M., Almeida, A. A., Rothe‐Neves, R., & Olchik, M. R. (2026) · Revista CEFAC · doi:10.1590/1982-0216/202628410625s
Grima-Terrén, M., Rommelfanger, M. K., Campanario, S., Calls, A., Cisneros, A., Ramírez‐Pardo, I., Chou, G., Zheng, Y., Hah, N., Serrano, A. L., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2613546123
The Role of Astrocytes in the Inflammatory Response in Neurodiseases
Peng, S., Wang, L., Ouyang, J., & 刘如恩 (2026) · MedComm · doi:10.1002/mco2.71069
Li, S., Liu, M., Zhang, P., Ma, X., & Xiaoping, C. H. E. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209264
He, Z., Zeng, J., Wang, G., Li, Y., & Zhang, F. (2026) · MedComm · doi:10.1002/mco2.71090
Gray, E. L., McGuiness, O., Menadue, C., Piper, A. J., WONG, K. K. H., Kiernan, M. C., & Yee, B. J. (2026) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2026.104667
Self-citationBindingDB (2025) · UC San Diego · doi:10.7270/q2474gh9
Kassubek, J., & Müller, H.-P. (2026) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-443-21425-7.01018-6
Zhao, T., Hoffman, M., Wu, G., & Belzil, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219632
Enhancing Machine Learning Performance for ALS Classification Using Feature Selection Technique
Dutt, A., Tiwari, A., Tripathi, S., Tiwari, P. K., Kumar, M., Dwivedi, A., Singh, K., Khare, A., Shukla, N. K., & Kumar, N. (2026) · Diagnostics · doi:10.3390/diagnostics16213573
Metadata
- Authors
- Goutman, S. A., Hardiman, O., Al-Chalabi, A., Chió, A., Savelieff, M. G., Kiernan, M. C., & Feldman, E. L.
- Affiliations
- University of Michigan (US)
- Trinity College Dublin (IE)
- University of Turin (IT)
- The University of Sydney (AU)
- Corresponding author
- Feldman, Eva L
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 21
- Issue
- 5
- Pages
- 480-493
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC9513753
- OpenAlex
- W4220676470
- Cited by
- 493
- References
- 107
- Citations by year
- 2026: 115 · 2025: 125 · 2024: 143 · 2023: 82 · 2022: 28
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Funders
- Seventh Framework Programme (259867)
- National Institute for Health Research Imperial Biomedical Research Centre
- Medical Research Council (MR/R024804/1, MR/L501529/1)
- Science Foundation Ireland (16/RC/3948, 13/RC2015)
- National Institute for Health Research (NIHR202421)
- National Institute of Neurological Disorders and Stroke (R01NS120926, R01NS127188)
- South London and Maudsley NHS Foundation Trust
- Ministero della Salute
- ALS Association
- National Institute of Environmental Health Sciences (R01ES030049, K23ES027221)
- Health Research Board
- National Health and Medical Research Council (APP1132524, APP1153439, APP1156093)
- University of Michigan
- Sinai Medical Staff Foundation
- Thierry Latran Foundation
- Horizon 2020
- Economic and Social Research Council (ES/L008238/1)
- Ministero dell’Istruzione, dell’Università e della Ricerca (2017SNW5MB)
- EU Joint Programme – Neurodegenerative Disease Research
- Motor Neurone Disease Association
- King's College London
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- amyotrophic lateral sclerosis, diagnosis, prognosis, survival models, disease staging, disease progression, fluid biomarkers, neuroimaging, phenotypes, end-of-life planning
- MeSH terms
- Amyotrophic Lateral Sclerosis, Electromyography, Humans, Prognosis, Biomarkers, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
